Daniel W. Gil

Allergan (United States)United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

24h-index2.1kcitations42works0.02yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?


Research Topics

Receptor Mechanisms and Signaling(13), Neuropeptides and Animal Physiology(8), Glaucoma and retinal disorders(7), Inflammatory mediators and NSAID effects(7), Estrogen and related hormone effects(7)

Publications42 total

Neurogastroenterology & Motility·2015· 30 citedOpen Access
Proceedings of the National Academy of Sciences·2012· 238 citedOpen Access
Localization Of α2A Adrenergic Receptors In Retina Of HATag-α2A Knock-In Mouse Model
2011
Inhibition of Hyperglycemia-Induced Blood Retinal Barrier Breakdown and Laser-Induced Choroidal Neovascularization by Brimonidine
2008
British Journal of Pharmacology·2007· 10 citedOpen Access
Memantine and Brimonidine Significantly Attenuate Vascular Endothelial Growth Factor (VEGF) Protein Levels in Diabetic Rat Retina
Investigative Ophthalmology & Visual Science·2006
Trends in Pharmacological Sciences·2004· 43 cited
Survey of Ophthalmology·2001· 106 cited
Survey of Ophthalmology·2001· 213 cited
page 1 of 3Next →

Frequent Co-authors

John E. Donello(16), David F. Woodward(11), Karen M. Kedzie(10), John W. Regan(8), E. Padillo(7), Kristen L. Pierce(6), Steven W. Andrews(5), Michael E. Garst(5), Jyotirmoy Kusari(5), Larry A. Wheeler(5), Robert M. Burk(4), Sheila Zhou(4), A M Bogardus(4), H A Krauss(4), Samuel J. Gillett(4), Taghreed Arefieg(4), Roshantha A.S. Chandraratna(4), L. A. Wheeler(3), Thomas J. Bailey(3), Mingting Tian(3)